Context Repeat transurethral resection (reTUR) is a guideline-recommended treatment
strategy in high-risk non–muscle-invasive bladder cancer (NMIBC) patients treated with …

Simple Summary The diagnosis and prediction of prognosis for bladder cancer (BC) can be
challenging because of the subjective nature of pathological evaluation. Artificial …

Background Although radical cystectomy (RC) is the standard of care for patients with
bacillus Calmette-Guérin (BCG)-unresponsive high-risk non–muscle-invasive bladder …

1.1 Aim and scope This overview represents the updated European Association of Urology
(EAU) Guidelines for Non-muscleinvasive Bladder Cancer (NMIBC), TaT1 and carcinoma in …

Purpose Predicting lymph node metastasis (LNM) in patients with bladder urothelial
carcinoma (BUC) before radical cystectomy aids clinical decision making. Here, we aimed to …

Objective To assess the association between cystoscopic findings and oncological
outcomes in patients with non‐muscle‐invasive bladder cancer (NMIBC) given that the …

Simple Summary The management of patients with non-muscle-invasive, high-grade
urothelial carcinoma represents a challenging issue for urologists. The ROL system is a …

Context.—Retraction artifact, paradoxic maturation/differentiation, desmoplasia, and
complex irregular growth are morphologic criteria of invasion in urothelial carcinoma …

Background To evaluate the safety profile and efficacy of intravesical gemcitabine as first-
line adjuvant therapy for non-muscle invasive bladder cancer (NMIBC) in the setting of …

Objectives To test if intravesical instillation of both an anti‐programmed cell death protein 1
(PD‐1) inhibitor and an oncolytic reovirus would demonstrate a greater effect than either …